Wedbush Analyst Reiterates Outperform Rating on Denali Therapeutics with 31 Price Target
Wedbush analyst Laura Chico has once again backed Denali Therapeutics (NASDAQ: DNLI) with an Outperform rating and a $31 price ...
Tag: DNLI
Kentucky Retirement System Increases Position in Denali Therapeutics, Despite Recent Losses
In a recent filing with the Securities & Exchange Commission, it was revealed that the Teachers Retirement System of The ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
